(Q45857377)

English

Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of recombinant factor VIII replacement therapy

scientific article published in June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of recombinant factor VIII replacement therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

0 references

Coagulation factor VIII

0 references

0 references

author name string

Giles AR

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

Rivard GE

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

Teitel J

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

Walker I

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

Transfusion science

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

19

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

139-148

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

Management of haemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications of hemophilia A treatment: factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Factor VIII inhibitors revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lessons from hemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the human factor VIII gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular cloning of a cDNA encoding human antihaemophilic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of active human factor VIII from recombinant DNA clones

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clotting factor VIII cloned

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute hepatitis A in haemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute hepatitis A in patients with haemophilia A.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of factor VIII mRNA and antigen in human liver and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure of human factor VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of frequent factor VIII replacement on the level of factor VIII antibodies in haemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900024-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0955-3886(98)00024-1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10187039

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45857377&oldid=2086733900"